Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro

• Results Overview

  This laboratory study showed that IL-13 affects genes associated with skin barrier function and inflammation in atopic dermatitis, and that tralokinumab can block these effects.

• Study Summary

  Num Participants:

  None

  Study Type:

  Observational

  Control Group:

  None

  Efficacy End Points Treatment:

  None

  Efficacy End Points Control:

  None

  Side Effects Treatment:

  Adverse Event	Severity	Percentage Affected

  Side Effects Control:

  Adverse Event	Severity	Percentage Affected